EUVIMEDEUVIMED entdecken
Crossref

Phillyrin improves pulmonary epithelial barrier dysfunction in LPS-induced acute lung injury through the RhoA/ROCK signaling pathway

Yingzheng Wang iD, Qianyuan Wu, Limei Li, Yubing Ke, Yixue Zhuang, Bingbing Cheng, Meixia Huang, Yinghao Wang

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgaf115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Yingzheng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Shangjie Town, Fuzhou, Fujian 350122, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Drugs, Chinese Herbal, rho-Associated Kinases, rho GTP-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project "clinical Chinese pharmacy", National Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project “clinical Chinese pharmacy”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Forsythiae Fructus, the fruit of Forsythia suspensa (Thunb.) Vahl, is a traditional Chinese medicine widely used for clearing heat and detoxifying and for treating inflammatory conditions such as fever and respiratory infection. Its effective ingredients include phillyrin, a lignan component with pharmacological properties, including anti-inflammation and antioxidation. This study investigated the effects of phillyrin on epithelial barrier dysfunction caused by acute lung injury (ALI) and key signaling pathways in rats with lipopolysaccharide (LPS)-induced ALI to explore its mechanism of attenuating ALI.

Results

Analysis of the lung wet/dry weight ratio, myeloperoxidase activity, pathological sections, and proinflammatory factor levels in vivo revealed that phillyrin could alleviate LPS-induced ALI. Network pharmacology showed 125 hub targets between phillyrin and ALI and indicated that the Rho activator (RhoA) was the main target in the enriched pathway, and the RhoA/Rho-associated protein kinase (ROCK) was pivotal in phillyrin’s therapeutic effects against ALI. Phillyrin improved tight junctions in the rats with LPS-induced ALI. In addition, western blot analyses revealed that phillyrin inhibited ALI-induced increments in RhoA, Rho-associated protein kinase 1, and myosin light-chain kinase proteins. Inhibitor experiments demonstrated that after fasudil inhibited the signaling pathway, phillyrin did not increase its inhibitory effect on key pathway proteins and its improvement effect on epithelial dysfunction.

Conclusions

Phillyrin inhibits pulmonary edema, suppresses inflammation and oxidative stress in ALI rats, and improves LPS-induced alveolar epithelial barrier dysfunction by inhibiting RhoA/ROCK pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryDrugs, Chinese Herbalrho-Associated Kinasesrho GTP-Binding ProteinsEpitheliumGlucosidesSignal TransductionForsythiaAnimalsRatsLignansOxidative StressPulmonary EdemaInflammationNetwork PharmacologyMaleRats, Sprague-Dawley

Stichwörter der Autor:innen

RhoA/ROCK signaling pathwayacute lung injuryepithelial barrier dysfunctionphillyrin

Substanzen

phillyrinGlucosidesDrugs, Chinese HerbalRhoA protein, ratrho-Associated Kinasesrho GTP-Binding ProteinsLignansROCK1 protein, rat

Autor:innen und Institutionen

  • College of Pharmacy, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Shangjie Town, Fuzhou, Fujian 350122, China.

ORCID-Profile: Yingzheng Wang

Förderung

  • National Natural Science Foundation of China
  • National Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project "clinical Chinese pharmacy"
  • National Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project “clinical Chinese pharmacy”

Zitieren

APA

Wang, Y., Wu, Q., Li, L., Ke, Y., Zhuang, Y., Cheng, B., Huang, M., & Wang, Y. (2026). Phillyrin improves pulmonary epithelial barrier dysfunction in LPS-induced acute lung injury through the RhoA/ROCK signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf115

Vancouver

Wang Y, Wu Q, Li L, Ke Y, Zhuang Y, Cheng B, et al. Phillyrin improves pulmonary epithelial barrier dysfunction in LPS-induced acute lung injury through the RhoA/ROCK signaling pathway. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf115

BibTeX
@article{Wang2026,
  author = {Wang, Yingzheng and Wu, Qianyuan and Li, Limei and Ke, Yubing and Zhuang, Yixue and Cheng, Bingbing and Huang, Meixia and Wang, Yinghao},
  title = {Phillyrin improves pulmonary epithelial barrier dysfunction in LPS-induced acute lung injury through the RhoA/ROCK signaling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgaf115}
}
Kostenlos starten →